Phivida Holdings Inc. (CSE:VIDA) has appointed healthcare veteran Mr. Richard Greatrex as The Company’s Vice President of Clinical Education. Mr. Greatrex will assume his new executive role as of February 1st, 2018 and immediately activate a global healthcare educational strategy to onboard and manage a significant back log of new clinic account prospects and continue to drive market share growth in fiscal 2018.
 Mr. Greatrex is a business development professional with a proven track record in healthcare and finance. His executive sales experience includes regional management at Eli Lilly, Bausch & Lomb, Allergan and Janssen. His career in the pharmaceutical sector has focused primarily on chronic pain and inflammatory based conditions.

Mr. Greatrex will work closely with the Clinical Advisory Team to drive new growth through continued medical education activities and strengthen key relationships with health care practitioner accounts. Ensuring a strong presence in these markets will be a major focus of the organization as Phivida captures a leadership share in 2018.
Phivida is dedicated to educating health care practitioners on effective ways of incorporating cannabinoid therapeutics into their licensed clinical practice. As VP of Clinical Education, Mr. Greatrex will be responsible for equipping and empowering doctors with the scientific information they need to confidently add Phivida’s CBD products into their clinical practice, administer CBD into their patient treatment strategies, and share their experiences with their fellow healthcare practitioners. Mr. Greatrex will also focus on the continued launch of the Vida+ line of clinical grade cannabidiol products across the Pacific USA and within the global medical community.
“Phivida is taking the right approach by focusing on community, education and sponsorship. I am thrilled to provide educational information and tools to the practitioners who need it most. As the WHO and WADA reports confirmed, cannabinoid treatment has a real place in clinical practice. This evidence is supported by thousands of clinical trials on www.pubmed.gov in which cannabidiol has shown positive outcomes in the treatment of debilitating inflammation-based disorders and diseases. I believe CBD will continue to change the lives of patients around the world by offering an alternative to pain relief, without the potential carrying costs of negative side effects which is so often seen with opiate based pharmaceuticals. I am very proud to be a part of that effort.”
Phivida Holdings Inc.
Phivida (pronounced “fi-VEE-da”) is a premier brand of cannabidiol (“CBD”) infused functional foods, beverages and clinical products – poised for global distribution. The World Anti-Doping Association’s recent decision to lift its ban of CBD from hemp oil and the World Health Organization’s recent statementsupporting the clinical benefits of CBD open the door for patients, practitioners, professional athletes and active professionals to begin using Phivida products in their daily lives. Celebrating Health and Wellness in Harmony, Phivida’s vision is to be a global leader in the alternative health sector while advancing education and research and investing back into the communities in which we operate.
Website www.phivida.com
Toll free +1 (844) 744-6646 (ext. #2)
Email IR@phivida.com
Phivida Holdings Inc. ©

 SOURCE Phivida Holdings Inc.

Click here to connect with Phivida Holdings Inc. (CSE:VIDA) to receive an Investors Presentation.


Source: www.prnewswire.com

World High Life Plc (“World High Life” or the “Company”)(AQSE:LIFE) (OTCQB:WRHLF), is pleased to announce that it has appointed H&P Advisory Limited (“Hannam & Partners”) as financial advisor to the Company with immediate effect

About Love Hemp

Keep reading... Show less

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:

Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.

Keep reading... Show less

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less